Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) Director Susan Elizabeth Knight acquired 11,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was bought at an average cost of $9.29 per share, for a total transaction of $102,190.00. Following the completion of the purchase, the director owned 11,000 shares of the company’s stock, valued at $102,190. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Anteris Technologies Global Price Performance
Shares of Anteris Technologies Global stock traded up $0.70 during midday trading on Thursday, reaching $9.65. The company had a trading volume of 2,120,513 shares, compared to its average volume of 1,152,635. The stock has a fifty day moving average price of $6.66 and a 200 day moving average price of $5.79. The firm has a market cap of $939.33 million, a PE ratio of -4.33 and a beta of 1.78. Anteris Technologies Global Corp. has a fifty-two week low of $2.85 and a fifty-two week high of $10.14.
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The company had revenue of $0.49 million during the quarter, compared to analyst estimates of $0.77 million. Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.During the same period in the prior year, the firm earned ($0.61) earnings per share. As a group, sell-side analysts forecast that Anteris Technologies Global Corp. will post -1.14 EPS for the current year.
Hedge Funds Weigh In On Anteris Technologies Global
Analyst Ratings Changes
Several equities analysts have issued reports on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Barclays boosted their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Cantor Fitzgerald reissued an “overweight” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research note on Friday, March 27th. Wall Street Zen raised Anteris Technologies Global from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Wells Fargo & Company began coverage on Anteris Technologies Global in a research report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 target price on the stock. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $16.00.
Check Out Our Latest Stock Report on AVR
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Recommended Stories
- Five stocks we like better than Anteris Technologies Global
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
